Rankings
▼
Calendar
KMDA Q1 2021 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$495M
Q1 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$25M
-25.2% YoY
Gross Profit
$9M
35.9% margin
Operating Income
$2M
9.5% margin
Net Income
$3M
10.8% margin
EPS (Diluted)
$0.06
QoQ Revenue Growth
-21.1%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$2M
Stock-Based Comp.
$215,000
Balance Sheet
Total Assets
$211M
Total Liabilities
$29M
Stockholders' Equity
$181M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$25M
$33M
-25.2%
Gross Profit
$9M
$11M
-22.0%
Operating Income
$2M
$5M
-51.3%
Net Income
$3M
$5M
-48.5%
← FY 2021
All Quarters
Q2 2021 →